Skip to content
Home/Companies/Biotech/Ability Pharma

Ability Pharma

Biotech·Spain·Active·14yr hold
Entry
2012
Hold
14yr
Status
Active

Who owns Ability Pharma?

Ability Pharma is currently owned by Inveready Asset Management through Inveready Biotech I (2010 vintage), since 2012.

Hand-verified · updated 2026-08-10

Inveready Asset Management
Investor
Inveready Asset Management
Inveready Biotech I · 2010 · Life Sciences VC

Key facts

HQSpain
SectorBiotech
StatusActive

More from Inveready Biotech I

Other portfolio companies in the same fund.

Avizorex Pharma
Active
BiotechSpain· 2014
Ojer Pharma
Ojer Pharma
Active
PharmaSpain· 2014
Reva Health
Active
HealthTechSpain· 2014
Minoryx
Minoryx
Active
BiotechSpain· 2013
Oncovision
Oncovision
Exited 2016
MedTechSpain· 2013
to
Atrys Health
Atrys Health
Active
HealthTechSpain· 2012

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Healx
Active
Amadeus Capital PartnersUK
Track Ability Pharma

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Ability Pharma.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue